Stocktoria
Nutex Health Inc. NUTX
Nutex Health Inc. (NUTX) earns a Piotroski F-score of 7/9 (strong financial health), with an Altman Z″ in the safe zone. It does not currently pay a dividend. FY2025 revenue was $875.3M at a 8.1% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Services · percentile among 982 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 7/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.415 |
| Retained earnings / assets | -0.312 |
| EBIT / assets | 0.3 |
| Equity / liabilities | 0.855 |
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| NUTX | Nutex Health Inc. | 7/9 | 4.62 | 16.2 | +82.4% |
| XBP | XBP Global Holdings, Inc. | 3/9 | — | — | — |
| ANDG | Andersen Group Inc. | 2/9 | -0.11 | — | +14.6% |
| PRTH | Priority Technology Holdings, Inc. | 3/9 | 0.52 | — | +8.3% |
| CTEV | Claritev Corp | 5/9 | -1.67 | — | +3.7% |
| GETY | Getty Images Holdings, Inc. | 2/9 | -1.63 | — | +4.5% |
| ACVA | ACV Auctions Inc. | 5/9 | 0.12 | — | +19.2% |
About Nutex Health Inc.
Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health. It also provides imaging services, such as CT scan, X-ray, MRI, ultrasound, etc.; laboratory services; and onsite inpatient pharmacies. The PHM segment provides management, administrative, and other support services to its affiliated hospitals and physician groups by establishing and operating provider networks, such as independent physician associations (IPAs); and a cloud-based technology platform for IPAs. The Real Estate segment owns and leases land and hospital buildings. Nutex Health Inc. was founded in 2011 and is headquartered in Houston, Texas.
FAQ
Is NUTX financially healthy?
Nutex Health Inc.'s Piotroski F-score is 7/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does NUTX pay a dividend?
No, Nutex Health Inc. does not currently pay a dividend.
How profitable is NUTX?
In FY2025, Nutex Health Inc. had a net margin of 8.1% and a return on equity of 16.7%.
What is NUTX's P/E ratio?
Nutex Health Inc.'s trailing price-to-earnings (P/E) ratio is about 16.2×, based on its latest annual earnings.
What is the analyst price target for NUTX?
The average Wall-Street price target for Nutex Health Inc. is $246.40, about 42.9% above the recent price, from 5 analysts (consensus: strong buy).
Is NUTX a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Nutex Health Inc.: a Piotroski F-score of 7/9, an Altman Z″ in the safe zone, a P/E of about 16.2×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.